Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.5.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.5.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.41EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.41EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.41ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.41ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.41EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.41EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.41ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.41ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.75.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BA.2.75.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BA.2.75.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.75.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.75.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.75.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.75.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
P.1.15 (Gamma)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
P.1.15 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.15 (Gamma)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
P.1.15 (Gamma)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
P.1.15 (Gamma)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
P.1.15 (Gamma)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
P.1.15 (Gamma)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
P.1.15 (Gamma)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.348EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.348EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.348ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.348ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.348EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.348EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.348ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.348ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.575EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.575EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.575ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.575ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.575EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.575EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.575ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.575ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.26EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
C.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.26ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
C.26ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
C.26EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
C.26EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
C.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used